With financial resiliency efforts, budget constraints, and staffing shortages likely to continue, 2023 could be the year when the operational efficiencies that result from partial IT outsourcing is one of your best options for staying on track with the technology innovations your healthcare organization needs.
Watch Now
Intranasal vaccination is an interesting and increasingly attractive alternative to improving the delivery of therapeutic vaccines. It comes with the promise of better efficacy by stimulating local mucosal response, needle-free delivery and could be self-administrable.
Watch Now
Business-review-webinars
Current drug development strategies are very expensive and lead to high drug attrition rates. One major reason for low success rates is the lack of predictive preclinical models for efficacy testing. The availability of induced pluripotent stem cell (hiPSC) technologies holds great promise to bring human biology to drug discovery but is still compromised by problems related to scalability, biological relevance, robustness and costs.
Watch Now
There has been growing interest in Pichia for use in the production of biopharmaceuticals including: SARS CoV2 spike protein and RBD, antibodies and other proteins for medicinal purposes.
Watch Now